Mostrando 3 resultados de: 3
Filtros aplicados
Publisher
Pharmacogenomics Journal(1)
Pharmacogenomics in Latin America: Challenges and Opportunities(1)
Pharmacology(1)
Origen
scopus(3)
CYP2C9 allele frequency differences between populations of Mexican-Mestizo, Mexican-Tepehuano, and Spaniards
ArticleAbstract: Earlier we had found that the CYP2C9*2 allelic frequency was lower in Mexican-Americans living in CaPalabras claves:CYP2C9, Hispanics, Mexican-Americans, Mexican-Mestizos, Mexican-Tepehuanos, pharmacogeneticsAutores:Adrián LLerena, Alanis-Bãuelos R.E., Dorado P., Lares-Asseff I., Licinio J., Penãs-Lledó E.M., Sosa-Macías M.G., Wong M.L.Fuentes:scopusInfluence of CYP2D6 deletion, multiplication, -1584C→G, 31G→A and 2988G→A gene polymorphisms on dextromethorphan metabolism among Mexican tepehuanos and mestizos
ArticleAbstract: The aim of this study was to explain the variability of CYP2D6 activity by the identification of CYPPalabras claves:allele frequency, CYP2D6 polymorphism, Dextromethorphan metabolism, Mexican TepehuanosAutores:Adrián LLerena, Alanis-Bãuelos R.E., Dorado P., Lares-Asseff I., Sosa-Macías M.G.Fuentes:scopusPharmacogenomic studies in Mexico, central America and Cuba in amerindians groups: Clinical applications and toxicology
Book PartAbstract: In Latin America, the first study focused on the pharmacogenetics of CYP2D6 was developed in 1986 byPalabras claves:Clinical pharmacology, Clinician toxicology, Latin America, pharmacogenetics, PharmacogenomicsAutores:Bailón-Soto C., Fausto Zaruma-Torres, Lares-Asseff I.Fuentes:scopus